VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,333,911 | -7.2% | 2,358,418 | +8.7% | 0.00% | 0.0% |
| Q2 2023 | $34,830,651 | +218.3% | 2,170,134 | +53.9% | 0.00% | – |
| Q1 2023 | $10,943,695 | -35.4% | 1,410,270 | +61.0% | 0.00% | -100.0% |
| Q4 2022 | $16,948,355 | +0.6% | 875,884 | +10.8% | 0.00% | 0.0% |
| Q3 2022 | $16,852,000 | +72.7% | 790,795 | +10.3% | 0.00% | – |
| Q2 2022 | $9,759,000 | -38.9% | 717,034 | +5.5% | 0.00% | – |
| Q1 2022 | $15,965,000 | +31.3% | 679,675 | +49.3% | 0.00% | – |
| Q4 2021 | $12,161,000 | +123.2% | 455,100 | +44.9% | 0.00% | – |
| Q3 2021 | $5,449,000 | +68012.5% | 314,037 | +52857.3% | 0.00% | – |
| Q2 2021 | $8,000 | – | 593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |